1/12
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Pregnancy and breastfeeding
avoid in breast feeding as present in milk
avoid especially 1st trimester risk teratogenicity
dose requirements increase 2nd and third trimester but returns normal after delivery
ensure effective contraception
Monitoring serum level concentrations
take levels 12 hours after dose aiming for 0.4-1mmol and lower dose in elderly
0.8-1mmol/l for acute episodes and previous relapses
monitor weekly after initiation and after each dose change until stable
monitor 3 monthly for a year then 6 months thereafter
Monitoring other parameters
Before initiaition
-cardiac - thyroid -renal functiion
-ECG - weight - FBC - U+E
during treatment
weight
U+E
EGFR
thyroid function
discontinuing lithium
avoid abrupt withdrawal high tisk relapse
reduce gradually over 4 weeks - 3 months (ideal)
monitor for relapse
if stopped abruptly consider atypical antipsychotic or valproate
patient/carer advice
report signs lithium toxicity:
-hypothyroidism weight gain
-renal dysfunction
-benign intracranial hypertension
maintain adequate fluid - hyponatraemia cause lithium toxicity
avoid diet change
maintain same brand and have treatment pack
interarctions increase lithium conc. (DAMNT)
diuretics
ACE/ARB
metronidazole
NSAIDS
Tetracyclines
Interactions decrease lithium conc.
antacids
urine alkaliniser
theophylline
osmotic and carbonic anhydrase inhibitor
interactions increase neurotoxicity
Carbamazepine
antipsychotics
SSRI
triptans
calcium channel blockers
interactions increase risk serotonin syndrome
SSRI
tramodol
st johns wort
sumatriptan